Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""EARLY detection of cancer"" wg kryterium: Temat


Starter badań:

Tytuł :
The association of sexual orientation with prostate, breast, and cervical cancer screening and diagnosis.
Autorzy :
Herriges MJ; Urology department, SUNY Upstate Medical University, Syracuse, NY, USA.
Pinkhasov R; Urology department, SUNY Upstate Medical University, Syracuse, NY, USA.
Lehavot K; VA Puget Sound Health Care System, Seattle, WA, USA.
Shapiro O; Urology department, SUNY Upstate Medical University, Syracuse, NY, USA.
Jacob JM; Urology department, SUNY Upstate Medical University, Syracuse, NY, USA.
Sanford T; Urology department, SUNY Upstate Medical University, Syracuse, NY, USA.
Liu N; Urology department, SUNY Upstate Medical University, Syracuse, NY, USA.
Bratslavsky G; Urology department, SUNY Upstate Medical University, Syracuse, NY, USA.
Goldberg H; Urology department, SUNY Upstate Medical University, Syracuse, NY, USA. .
Pokaż więcej
Źródło :
Cancer causes & control : CCC [Cancer Causes Control] 2022 Dec; Vol. 33 (12), pp. 1421-1430. Date of Electronic Publication: 2022 Sep 09.
Typ publikacji :
Journal Article
MeSH Terms :
Early Detection of Cancer*
Uterine Cervical Neoplasms*/diagnosis
Uterine Cervical Neoplasms*/epidemiology
Female ; Humans ; Male ; Cross-Sectional Studies ; Prostate ; Sexual Behavior
Czasopismo naukowe
Tytuł :
Evaluation of benefits and harms of adaptive screening schedules for lung cancer: A microsimulation study.
Autorzy :
Cao P; Department of Epidemiology, 1259University of Michigan, Ann Arbor, MI, USA.
Jeon J; Department of Epidemiology, 1259University of Michigan, Ann Arbor, MI, USA.
Meza R; Department of Epidemiology, 1259University of Michigan, Ann Arbor, MI, USA.
Pokaż więcej
Źródło :
Journal of medical screening [J Med Screen] 2022 Dec; Vol. 29 (4), pp. 260-267. Date of Electronic Publication: 2022 Aug 22.
Typ publikacji :
Journal Article
MeSH Terms :
Early Detection of Cancer*/adverse effects
Early Detection of Cancer*/methods
Lung Neoplasms*/diagnosis
Humans ; Mass Screening/methods ; Quality-Adjusted Life Years ; Time Factors
Czasopismo naukowe
Tytuł :
Trends of Colorectal Cancer Screening Rates in Korea: Korean National Cancer Screening Survey 2005-2020.
Autorzy :
Park B; Department of Preventive Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
Lee YY; National Cancer Control Institute, Goyang, Korea.
Song SY; National Cancer Control Institute, Goyang, Korea.
Shin HY; National Cancer Control Institute, Goyang, Korea.
Suh M; National Cancer Control Institute, Goyang, Korea.; Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.
Choi KS; National Cancer Control Institute, Goyang, Korea.; Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.
Jun JK; National Cancer Control Institute, Goyang, Korea.; Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.
Pokaż więcej
Źródło :
Gut and liver [Gut Liver] 2022 Nov 15; Vol. 16 (6), pp. 930-941. Date of Electronic Publication: 2022 Apr 22.
Typ publikacji :
Journal Article
MeSH Terms :
Early Detection of Cancer*
Colorectal Neoplasms*/diagnosis
Colorectal Neoplasms*/epidemiology
Adult ; Humans ; Occult Blood ; Colonoscopy ; Mass Screening ; Republic of Korea/epidemiology
Czasopismo naukowe
Tytuł :
The impact of pre-notifications and reminders on participation in colorectal cancer screening - A randomised controlled trial.
Autorzy :
Larsen MB; University Research Clinic for Cancer Screening, Department of Public Health Programmes, Randers Regional Hospital, Central Denmark Region, Skovlyvej 15, DK-8930 Randers, NO, Denmark. Electronic address: .
Hedelund M; University Research Clinic for Cancer Screening, Department of Public Health Programmes, Randers Regional Hospital, Central Denmark Region, Skovlyvej 15, DK-8930 Randers, NO, Denmark.
Flander L; University of Melbourne, School of Population and Global Health, The University of Melbourne, Victoria 3010, Australia.
Andersen B; University Research Clinic for Cancer Screening, Department of Public Health Programmes, Randers Regional Hospital, Central Denmark Region, Skovlyvej 15, DK-8930 Randers, NO, Denmark; Department of Clinical Medicine, Aarhus University, Incuba Skejby, Building 2, Palle Juul-Jensens Boulevard 82, DK-8200 Aarhus N, Denmark.
Pokaż więcej
Źródło :
Preventive medicine [Prev Med] 2022 Nov; Vol. 164, pp. 107229. Date of Electronic Publication: 2022 Aug 31.
Typ publikacji :
Randomized Controlled Trial; Journal Article
MeSH Terms :
Early Detection of Cancer*
Colorectal Neoplasms*/diagnosis
Colorectal Neoplasms*/prevention & control
Female ; Male ; Humans ; Middle Aged
Czasopismo naukowe
Tytuł :
Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death.
Autorzy :
Bretthauer M; From the Clinical Effectiveness Research Group (M. Bretthauer, M.L., P.W., M.K., K.G., M. Bugajski, Ø.H., H.-O.A., M.F.K.) and the Department of General Practice, Institute of Health and Society (L.E.), University of Oslo, the Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital (M. Bretthauer, M.L., M.K., K.G., Ø.H., H.-O.A.), and the Cancer Registry of Norway (G.H.), Oslo, the Institute of Clinical Medicine, University of Tromsø, Tromsø (M. Bretthauer), and the Department of Research and Development, Telemark Hospital, Skien (G.H.) - all in Norway; the Department of Gastroenterological Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), and the Departments of Pathology (A.M.) and Gastroenterological Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), Medical Center of Postgraduate Education - both in Warsaw, Poland; Vårdcentralen Värmlands Nysäter and the Center for Clinical Research, County Council of Värmland, Karlsdad (L.E.), and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna (L.E., H.-O.A.) - both in Sweden; the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, and the University of Amsterdam, Amsterdam (E.D.), and the Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam (M.S., E.J.K.) - all in the Netherlands; the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (A.G.Z.); and CAUSALab, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (J.S., M.A.H.).
Løberg M; From the Clinical Effectiveness Research Group (M. Bretthauer, M.L., P.W., M.K., K.G., M. Bugajski, Ø.H., H.-O.A., M.F.K.) and the Department of General Practice, Institute of Health and Society (L.E.), University of Oslo, the Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital (M. Bretthauer, M.L., M.K., K.G., Ø.H., H.-O.A.), and the Cancer Registry of Norway (G.H.), Oslo, the Institute of Clinical Medicine, University of Tromsø, Tromsø (M. Bretthauer), and the Department of Research and Development, Telemark Hospital, Skien (G.H.) - all in Norway; the Department of Gastroenterological Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), and the Departments of Pathology (A.M.) and Gastroenterological Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), Medical Center of Postgraduate Education - both in Warsaw, Poland; Vårdcentralen Värmlands Nysäter and the Center for Clinical Research, County Council of Värmland, Karlsdad (L.E.), and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna (L.E., H.-O.A.) - both in Sweden; the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, and the University of Amsterdam, Amsterdam (E.D.), and the Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam (M.S., E.J.K.) - all in the Netherlands; the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (A.G.Z.); and CAUSALab, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (J.S., M.A.H.).
Wieszczy P; From the Clinical Effectiveness Research Group (M. Bretthauer, M.L., P.W., M.K., K.G., M. Bugajski, Ø.H., H.-O.A., M.F.K.) and the Department of General Practice, Institute of Health and Society (L.E.), University of Oslo, the Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital (M. Bretthauer, M.L., M.K., K.G., Ø.H., H.-O.A.), and the Cancer Registry of Norway (G.H.), Oslo, the Institute of Clinical Medicine, University of Tromsø, Tromsø (M. Bretthauer), and the Department of Research and Development, Telemark Hospital, Skien (G.H.) - all in Norway; the Department of Gastroenterological Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), and the Departments of Pathology (A.M.) and Gastroenterological Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), Medical Center of Postgraduate Education - both in Warsaw, Poland; Vårdcentralen Värmlands Nysäter and the Center for Clinical Research, County Council of Värmland, Karlsdad (L.E.), and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna (L.E., H.-O.A.) - both in Sweden; the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, and the University of Amsterdam, Amsterdam (E.D.), and the Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam (M.S., E.J.K.) - all in the Netherlands; the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (A.G.Z.); and CAUSALab, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (J.S., M.A.H.).
Kalager M; From the Clinical Effectiveness Research Group (M. Bretthauer, M.L., P.W., M.K., K.G., M. Bugajski, Ø.H., H.-O.A., M.F.K.) and the Department of General Practice, Institute of Health and Society (L.E.), University of Oslo, the Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital (M. Bretthauer, M.L., M.K., K.G., Ø.H., H.-O.A.), and the Cancer Registry of Norway (G.H.), Oslo, the Institute of Clinical Medicine, University of Tromsø, Tromsø (M. Bretthauer), and the Department of Research and Development, Telemark Hospital, Skien (G.H.) - all in Norway; the Department of Gastroenterological Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), and the Departments of Pathology (A.M.) and Gastroenterological Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), Medical Center of Postgraduate Education - both in Warsaw, Poland; Vårdcentralen Värmlands Nysäter and the Center for Clinical Research, County Council of Värmland, Karlsdad (L.E.), and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna (L.E., H.-O.A.) - both in Sweden; the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, and the University of Amsterdam, Amsterdam (E.D.), and the Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam (M.S., E.J.K.) - all in the Netherlands; the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (A.G.Z.); and CAUSALab, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (J.S., M.A.H.).
Emilsson L; From the Clinical Effectiveness Research Group (M. Bretthauer, M.L., P.W., M.K., K.G., M. Bugajski, Ø.H., H.-O.A., M.F.K.) and the Department of General Practice, Institute of Health and Society (L.E.), University of Oslo, the Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital (M. Bretthauer, M.L., M.K., K.G., Ø.H., H.-O.A.), and the Cancer Registry of Norway (G.H.), Oslo, the Institute of Clinical Medicine, University of Tromsø, Tromsø (M. Bretthauer), and the Department of Research and Development, Telemark Hospital, Skien (G.H.) - all in Norway; the Department of Gastroenterological Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), and the Departments of Pathology (A.M.) and Gastroenterological Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), Medical Center of Postgraduate Education - both in Warsaw, Poland; Vårdcentralen Värmlands Nysäter and the Center for Clinical Research, County Council of Värmland, Karlsdad (L.E.), and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna (L.E., H.-O.A.) - both in Sweden; the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, and the University of Amsterdam, Amsterdam (E.D.), and the Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam (M.S., E.J.K.) - all in the Netherlands; the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (A.G.Z.); and CAUSALab, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (J.S., M.A.H.).
Garborg K; From the Clinical Effectiveness Research Group (M. Bretthauer, M.L., P.W., M.K., K.G., M. Bugajski, Ø.H., H.-O.A., M.F.K.) and the Department of General Practice, Institute of Health and Society (L.E.), University of Oslo, the Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital (M. Bretthauer, M.L., M.K., K.G., Ø.H., H.-O.A.), and the Cancer Registry of Norway (G.H.), Oslo, the Institute of Clinical Medicine, University of Tromsø, Tromsø (M. Bretthauer), and the Department of Research and Development, Telemark Hospital, Skien (G.H.) - all in Norway; the Department of Gastroenterological Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), and the Departments of Pathology (A.M.) and Gastroenterological Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), Medical Center of Postgraduate Education - both in Warsaw, Poland; Vårdcentralen Värmlands Nysäter and the Center for Clinical Research, County Council of Värmland, Karlsdad (L.E.), and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna (L.E., H.-O.A.) - both in Sweden; the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, and the University of Amsterdam, Amsterdam (E.D.), and the Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam (M.S., E.J.K.) - all in the Netherlands; the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (A.G.Z.); and CAUSALab, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (J.S., M.A.H.).
Rupinski M; From the Clinical Effectiveness Research Group (M. Bretthauer, M.L., P.W., M.K., K.G., M. Bugajski, Ø.H., H.-O.A., M.F.K.) and the Department of General Practice, Institute of Health and Society (L.E.), University of Oslo, the Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital (M. Bretthauer, M.L., M.K., K.G., Ø.H., H.-O.A.), and the Cancer Registry of Norway (G.H.), Oslo, the Institute of Clinical Medicine, University of Tromsø, Tromsø (M. Bretthauer), and the Department of Research and Development, Telemark Hospital, Skien (G.H.) - all in Norway; the Department of Gastroenterological Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), and the Departments of Pathology (A.M.) and Gastroenterological Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), Medical Center of Postgraduate Education - both in Warsaw, Poland; Vårdcentralen Värmlands Nysäter and the Center for Clinical Research, County Council of Värmland, Karlsdad (L.E.), and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna (L.E., H.-O.A.) - both in Sweden; the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, and the University of Amsterdam, Amsterdam (E.D.), and the Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam (M.S., E.J.K.) - all in the Netherlands; the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (A.G.Z.); and CAUSALab, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (J.S., M.A.H.).
Dekker E; From the Clinical Effectiveness Research Group (M. Bretthauer, M.L., P.W., M.K., K.G., M. Bugajski, Ø.H., H.-O.A., M.F.K.) and the Department of General Practice, Institute of Health and Society (L.E.), University of Oslo, the Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital (M. Bretthauer, M.L., M.K., K.G., Ø.H., H.-O.A.), and the Cancer Registry of Norway (G.H.), Oslo, the Institute of Clinical Medicine, University of Tromsø, Tromsø (M. Bretthauer), and the Department of Research and Development, Telemark Hospital, Skien (G.H.) - all in Norway; the Department of Gastroenterological Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), and the Departments of Pathology (A.M.) and Gastroenterological Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), Medical Center of Postgraduate Education - both in Warsaw, Poland; Vårdcentralen Värmlands Nysäter and the Center for Clinical Research, County Council of Värmland, Karlsdad (L.E.), and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna (L.E., H.-O.A.) - both in Sweden; the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, and the University of Amsterdam, Amsterdam (E.D.), and the Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam (M.S., E.J.K.) - all in the Netherlands; the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (A.G.Z.); and CAUSALab, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (J.S., M.A.H.).
Spaander M; From the Clinical Effectiveness Research Group (M. Bretthauer, M.L., P.W., M.K., K.G., M. Bugajski, Ø.H., H.-O.A., M.F.K.) and the Department of General Practice, Institute of Health and Society (L.E.), University of Oslo, the Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital (M. Bretthauer, M.L., M.K., K.G., Ø.H., H.-O.A.), and the Cancer Registry of Norway (G.H.), Oslo, the Institute of Clinical Medicine, University of Tromsø, Tromsø (M. Bretthauer), and the Department of Research and Development, Telemark Hospital, Skien (G.H.) - all in Norway; the Department of Gastroenterological Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), and the Departments of Pathology (A.M.) and Gastroenterological Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), Medical Center of Postgraduate Education - both in Warsaw, Poland; Vårdcentralen Värmlands Nysäter and the Center for Clinical Research, County Council of Värmland, Karlsdad (L.E.), and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna (L.E., H.-O.A.) - both in Sweden; the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, and the University of Amsterdam, Amsterdam (E.D.), and the Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam (M.S., E.J.K.) - all in the Netherlands; the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (A.G.Z.); and CAUSALab, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (J.S., M.A.H.).
Bugajski M; From the Clinical Effectiveness Research Group (M. Bretthauer, M.L., P.W., M.K., K.G., M. Bugajski, Ø.H., H.-O.A., M.F.K.) and the Department of General Practice, Institute of Health and Society (L.E.), University of Oslo, the Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital (M. Bretthauer, M.L., M.K., K.G., Ø.H., H.-O.A.), and the Cancer Registry of Norway (G.H.), Oslo, the Institute of Clinical Medicine, University of Tromsø, Tromsø (M. Bretthauer), and the Department of Research and Development, Telemark Hospital, Skien (G.H.) - all in Norway; the Department of Gastroenterological Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), and the Departments of Pathology (A.M.) and Gastroenterological Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), Medical Center of Postgraduate Education - both in Warsaw, Poland; Vårdcentralen Värmlands Nysäter and the Center for Clinical Research, County Council of Värmland, Karlsdad (L.E.), and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna (L.E., H.-O.A.) - both in Sweden; the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, and the University of Amsterdam, Amsterdam (E.D.), and the Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam (M.S., E.J.K.) - all in the Netherlands; the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (A.G.Z.); and CAUSALab, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (J.S., M.A.H.).
Holme Ø; From the Clinical Effectiveness Research Group (M. Bretthauer, M.L., P.W., M.K., K.G., M. Bugajski, Ø.H., H.-O.A., M.F.K.) and the Department of General Practice, Institute of Health and Society (L.E.), University of Oslo, the Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital (M. Bretthauer, M.L., M.K., K.G., Ø.H., H.-O.A.), and the Cancer Registry of Norway (G.H.), Oslo, the Institute of Clinical Medicine, University of Tromsø, Tromsø (M. Bretthauer), and the Department of Research and Development, Telemark Hospital, Skien (G.H.) - all in Norway; the Department of Gastroenterological Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), and the Departments of Pathology (A.M.) and Gastroenterological Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), Medical Center of Postgraduate Education - both in Warsaw, Poland; Vårdcentralen Värmlands Nysäter and the Center for Clinical Research, County Council of Värmland, Karlsdad (L.E.), and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna (L.E., H.-O.A.) - both in Sweden; the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, and the University of Amsterdam, Amsterdam (E.D.), and the Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam (M.S., E.J.K.) - all in the Netherlands; the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (A.G.Z.); and CAUSALab, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (J.S., M.A.H.).
Zauber AG; From the Clinical Effectiveness Research Group (M. Bretthauer, M.L., P.W., M.K., K.G., M. Bugajski, Ø.H., H.-O.A., M.F.K.) and the Department of General Practice, Institute of Health and Society (L.E.), University of Oslo, the Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital (M. Bretthauer, M.L., M.K., K.G., Ø.H., H.-O.A.), and the Cancer Registry of Norway (G.H.), Oslo, the Institute of Clinical Medicine, University of Tromsø, Tromsø (M. Bretthauer), and the Department of Research and Development, Telemark Hospital, Skien (G.H.) - all in Norway; the Department of Gastroenterological Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), and the Departments of Pathology (A.M.) and Gastroenterological Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), Medical Center of Postgraduate Education - both in Warsaw, Poland; Vårdcentralen Värmlands Nysäter and the Center for Clinical Research, County Council of Värmland, Karlsdad (L.E.), and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna (L.E., H.-O.A.) - both in Sweden; the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, and the University of Amsterdam, Amsterdam (E.D.), and the Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam (M.S., E.J.K.) - all in the Netherlands; the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (A.G.Z.); and CAUSALab, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (J.S., M.A.H.).
Pilonis ND; From the Clinical Effectiveness Research Group (M. Bretthauer, M.L., P.W., M.K., K.G., M. Bugajski, Ø.H., H.-O.A., M.F.K.) and the Department of General Practice, Institute of Health and Society (L.E.), University of Oslo, the Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital (M. Bretthauer, M.L., M.K., K.G., Ø.H., H.-O.A.), and the Cancer Registry of Norway (G.H.), Oslo, the Institute of Clinical Medicine, University of Tromsø, Tromsø (M. Bretthauer), and the Department of Research and Development, Telemark Hospital, Skien (G.H.) - all in Norway; the Department of Gastroenterological Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), and the Departments of Pathology (A.M.) and Gastroenterological Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), Medical Center of Postgraduate Education - both in Warsaw, Poland; Vårdcentralen Värmlands Nysäter and the Center for Clinical Research, County Council of Värmland, Karlsdad (L.E.), and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna (L.E., H.-O.A.) - both in Sweden; the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, and the University of Amsterdam, Amsterdam (E.D.), and the Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam (M.S., E.J.K.) - all in the Netherlands; the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (A.G.Z.); and CAUSALab, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (J.S., M.A.H.).
Mroz A; From the Clinical Effectiveness Research Group (M. Bretthauer, M.L., P.W., M.K., K.G., M. Bugajski, Ø.H., H.-O.A., M.F.K.) and the Department of General Practice, Institute of Health and Society (L.E.), University of Oslo, the Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital (M. Bretthauer, M.L., M.K., K.G., Ø.H., H.-O.A.), and the Cancer Registry of Norway (G.H.), Oslo, the Institute of Clinical Medicine, University of Tromsø, Tromsø (M. Bretthauer), and the Department of Research and Development, Telemark Hospital, Skien (G.H.) - all in Norway; the Department of Gastroenterological Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), and the Departments of Pathology (A.M.) and Gastroenterological Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), Medical Center of Postgraduate Education - both in Warsaw, Poland; Vårdcentralen Värmlands Nysäter and the Center for Clinical Research, County Council of Värmland, Karlsdad (L.E.), and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna (L.E., H.-O.A.) - both in Sweden; the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, and the University of Amsterdam, Amsterdam (E.D.), and the Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam (M.S., E.J.K.) - all in the Netherlands; the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (A.G.Z.); and CAUSALab, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (J.S., M.A.H.).
Kuipers EJ; From the Clinical Effectiveness Research Group (M. Bretthauer, M.L., P.W., M.K., K.G., M. Bugajski, Ø.H., H.-O.A., M.F.K.) and the Department of General Practice, Institute of Health and Society (L.E.), University of Oslo, the Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital (M. Bretthauer, M.L., M.K., K.G., Ø.H., H.-O.A.), and the Cancer Registry of Norway (G.H.), Oslo, the Institute of Clinical Medicine, University of Tromsø, Tromsø (M. Bretthauer), and the Department of Research and Development, Telemark Hospital, Skien (G.H.) - all in Norway; the Department of Gastroenterological Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), and the Departments of Pathology (A.M.) and Gastroenterological Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), Medical Center of Postgraduate Education - both in Warsaw, Poland; Vårdcentralen Värmlands Nysäter and the Center for Clinical Research, County Council of Värmland, Karlsdad (L.E.), and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna (L.E., H.-O.A.) - both in Sweden; the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, and the University of Amsterdam, Amsterdam (E.D.), and the Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam (M.S., E.J.K.) - all in the Netherlands; the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (A.G.Z.); and CAUSALab, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (J.S., M.A.H.).
Shi J; From the Clinical Effectiveness Research Group (M. Bretthauer, M.L., P.W., M.K., K.G., M. Bugajski, Ø.H., H.-O.A., M.F.K.) and the Department of General Practice, Institute of Health and Society (L.E.), University of Oslo, the Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital (M. Bretthauer, M.L., M.K., K.G., Ø.H., H.-O.A.), and the Cancer Registry of Norway (G.H.), Oslo, the Institute of Clinical Medicine, University of Tromsø, Tromsø (M. Bretthauer), and the Department of Research and Development, Telemark Hospital, Skien (G.H.) - all in Norway; the Department of Gastroenterological Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), and the Departments of Pathology (A.M.) and Gastroenterological Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), Medical Center of Postgraduate Education - both in Warsaw, Poland; Vårdcentralen Värmlands Nysäter and the Center for Clinical Research, County Council of Värmland, Karlsdad (L.E.), and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna (L.E., H.-O.A.) - both in Sweden; the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, and the University of Amsterdam, Amsterdam (E.D.), and the Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam (M.S., E.J.K.) - all in the Netherlands; the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (A.G.Z.); and CAUSALab, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (J.S., M.A.H.).
Hernán MA; From the Clinical Effectiveness Research Group (M. Bretthauer, M.L., P.W., M.K., K.G., M. Bugajski, Ø.H., H.-O.A., M.F.K.) and the Department of General Practice, Institute of Health and Society (L.E.), University of Oslo, the Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital (M. Bretthauer, M.L., M.K., K.G., Ø.H., H.-O.A.), and the Cancer Registry of Norway (G.H.), Oslo, the Institute of Clinical Medicine, University of Tromsø, Tromsø (M. Bretthauer), and the Department of Research and Development, Telemark Hospital, Skien (G.H.) - all in Norway; the Department of Gastroenterological Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), and the Departments of Pathology (A.M.) and Gastroenterological Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), Medical Center of Postgraduate Education - both in Warsaw, Poland; Vårdcentralen Värmlands Nysäter and the Center for Clinical Research, County Council of Värmland, Karlsdad (L.E.), and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna (L.E., H.-O.A.) - both in Sweden; the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, and the University of Amsterdam, Amsterdam (E.D.), and the Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam (M.S., E.J.K.) - all in the Netherlands; the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (A.G.Z.); and CAUSALab, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (J.S., M.A.H.).
Adami HO; From the Clinical Effectiveness Research Group (M. Bretthauer, M.L., P.W., M.K., K.G., M. Bugajski, Ø.H., H.-O.A., M.F.K.) and the Department of General Practice, Institute of Health and Society (L.E.), University of Oslo, the Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital (M. Bretthauer, M.L., M.K., K.G., Ø.H., H.-O.A.), and the Cancer Registry of Norway (G.H.), Oslo, the Institute of Clinical Medicine, University of Tromsø, Tromsø (M. Bretthauer), and the Department of Research and Development, Telemark Hospital, Skien (G.H.) - all in Norway; the Department of Gastroenterological Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), and the Departments of Pathology (A.M.) and Gastroenterological Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), Medical Center of Postgraduate Education - both in Warsaw, Poland; Vårdcentralen Värmlands Nysäter and the Center for Clinical Research, County Council of Värmland, Karlsdad (L.E.), and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna (L.E., H.-O.A.) - both in Sweden; the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, and the University of Amsterdam, Amsterdam (E.D.), and the Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam (M.S., E.J.K.) - all in the Netherlands; the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (A.G.Z.); and CAUSALab, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (J.S., M.A.H.).
Regula J; From the Clinical Effectiveness Research Group (M. Bretthauer, M.L., P.W., M.K., K.G., M. Bugajski, Ø.H., H.-O.A., M.F.K.) and the Department of General Practice, Institute of Health and Society (L.E.), University of Oslo, the Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital (M. Bretthauer, M.L., M.K., K.G., Ø.H., H.-O.A.), and the Cancer Registry of Norway (G.H.), Oslo, the Institute of Clinical Medicine, University of Tromsø, Tromsø (M. Bretthauer), and the Department of Research and Development, Telemark Hospital, Skien (G.H.) - all in Norway; the Department of Gastroenterological Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), and the Departments of Pathology (A.M.) and Gastroenterological Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), Medical Center of Postgraduate Education - both in Warsaw, Poland; Vårdcentralen Värmlands Nysäter and the Center for Clinical Research, County Council of Värmland, Karlsdad (L.E.), and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna (L.E., H.-O.A.) - both in Sweden; the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, and the University of Amsterdam, Amsterdam (E.D.), and the Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam (M.S., E.J.K.) - all in the Netherlands; the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (A.G.Z.); and CAUSALab, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (J.S., M.A.H.).
Hoff G; From the Clinical Effectiveness Research Group (M. Bretthauer, M.L., P.W., M.K., K.G., M. Bugajski, Ø.H., H.-O.A., M.F.K.) and the Department of General Practice, Institute of Health and Society (L.E.), University of Oslo, the Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital (M. Bretthauer, M.L., M.K., K.G., Ø.H., H.-O.A.), and the Cancer Registry of Norway (G.H.), Oslo, the Institute of Clinical Medicine, University of Tromsø, Tromsø (M. Bretthauer), and the Department of Research and Development, Telemark Hospital, Skien (G.H.) - all in Norway; the Department of Gastroenterological Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), and the Departments of Pathology (A.M.) and Gastroenterological Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), Medical Center of Postgraduate Education - both in Warsaw, Poland; Vårdcentralen Värmlands Nysäter and the Center for Clinical Research, County Council of Värmland, Karlsdad (L.E.), and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna (L.E., H.-O.A.) - both in Sweden; the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, and the University of Amsterdam, Amsterdam (E.D.), and the Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam (M.S., E.J.K.) - all in the Netherlands; the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (A.G.Z.); and CAUSALab, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (J.S., M.A.H.).
Kaminski MF; From the Clinical Effectiveness Research Group (M. Bretthauer, M.L., P.W., M.K., K.G., M. Bugajski, Ø.H., H.-O.A., M.F.K.) and the Department of General Practice, Institute of Health and Society (L.E.), University of Oslo, the Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital (M. Bretthauer, M.L., M.K., K.G., Ø.H., H.-O.A.), and the Cancer Registry of Norway (G.H.), Oslo, the Institute of Clinical Medicine, University of Tromsø, Tromsø (M. Bretthauer), and the Department of Research and Development, Telemark Hospital, Skien (G.H.) - all in Norway; the Department of Gastroenterological Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), and the Departments of Pathology (A.M.) and Gastroenterological Oncology (P.W., M.R., M. Bugajski, N.D.P., A.M., J.R., M.F.K.), Medical Center of Postgraduate Education - both in Warsaw, Poland; Vårdcentralen Värmlands Nysäter and the Center for Clinical Research, County Council of Värmland, Karlsdad (L.E.), and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna (L.E., H.-O.A.) - both in Sweden; the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, and the University of Amsterdam, Amsterdam (E.D.), and the Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam (M.S., E.J.K.) - all in the Netherlands; the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York (A.G.Z.); and CAUSALab, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (J.S., M.A.H.).
Pokaż więcej
Corporate Authors :
NordICC Study Group
Źródło :
The New England journal of medicine [N Engl J Med] 2022 Oct 27; Vol. 387 (17), pp. 1547-1556. Date of Electronic Publication: 2022 Oct 09.
Typ publikacji :
Journal Article; Pragmatic Clinical Trial; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Colonoscopy*/adverse effects
Colonoscopy*/methods
Colonoscopy*/statistics & numerical data
Colorectal Neoplasms*/diagnosis
Colorectal Neoplasms*/epidemiology
Colorectal Neoplasms*/mortality
Early Detection of Cancer*/adverse effects
Early Detection of Cancer*/methods
Early Detection of Cancer*/statistics & numerical data
Mass Screening*/adverse effects
Mass Screening*/methods
Mass Screening*/statistics & numerical data
Female ; Humans ; Male ; Middle Aged ; Colonic Polyps/diagnosis ; Colonic Polyps/epidemiology ; Colonic Polyps/surgery ; Europe/epidemiology ; Odds Ratio ; Risk ; Follow-Up Studies
Czasopismo naukowe
Tytuł :
Physician Adenoma Detection Rates and Colorectal Cancer.
Autorzy :
Schell MJ; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center and Research Institute, Tampa, Florida.
Gwede CK; Department of Health Outcomes and Behavior, Moffitt Cancer Center and Research Institute, Tampa, Florida.
Friedman M; Department of Gastrointestinal Oncology, Moffitt Cancer Center and Research Institute, Tampa, Florida.
Pokaż więcej
Źródło :
JAMA [JAMA] 2022 Oct 11; Vol. 328 (14), pp. 1462.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Adenoma*/diagnosis
Adenoma*/epidemiology
Colorectal Neoplasms*/diagnosis
Colorectal Neoplasms*/epidemiology
Early Detection of Cancer*/methods
Early Detection of Cancer*/statistics & numerical data
Physicians*/statistics & numerical data
Colonoscopy ; Humans
Czasopismo naukowe
Tytuł :
Physician Adenoma Detection Rates and Colorectal Cancer-Reply.
Autorzy :
Corley DA; Division of Research, Kaiser Permanente Northern California, Oakland.
Schottinger J; Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California.
Jensen C; Division of Research, Kaiser Permanente Northern California, Oakland.
Pokaż więcej
Źródło :
JAMA [JAMA] 2022 Oct 11; Vol. 328 (14), pp. 1462-1463.
Typ publikacji :
Letter; Comment
MeSH Terms :
Adenoma*/diagnosis
Adenoma*/epidemiology
Colorectal Neoplasms*/diagnosis
Colorectal Neoplasms*/epidemiology
Early Detection of Cancer*/methods
Early Detection of Cancer*/statistics & numerical data
Physicians*/statistics & numerical data
Colonoscopy/statistics & numerical data ; Humans
Opinia redakcyjna
Tytuł :
Physician Adenoma Detection Rates and Colorectal Cancer.
Autorzy :
Colloff E; Stanford, California.
Pokaż więcej
Źródło :
JAMA [JAMA] 2022 Oct 11; Vol. 328 (14), pp. 1461.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Adenoma*/diagnosis
Adenoma*/epidemiology
Colorectal Neoplasms*/diagnosis
Colorectal Neoplasms*/epidemiology
Early Detection of Cancer*/methods
Early Detection of Cancer*/statistics & numerical data
Physicians*/statistics & numerical data
Colonoscopy/statistics & numerical data ; Humans
Czasopismo naukowe
Tytuł :
[Epilepsy in cancer patients: primary prevention and the importance of high-risk patient screening].
Autorzy :
López-Anguita S; Hospital Central de la Defensa Gómez Ulla, Madrid, España.
Gutiérrez-Ruano B; Hospital Central de la Defensa Gómez Ulla, Madrid, España.
Muñoz-González A; Hospital Central de la Defensa Gómez Ulla, Madrid, España.
Valenzuela-Rojas FJ; Hospital Central de la Defensa Gómez Ulla, Madrid, España.
Olmedilla-González MN; Hospital Central de la Defensa Gómez Ulla, Madrid, España.
Pokaż więcej
Transliterated Title :
Epilepsia en el paciente oncológico: prevención primaria e importancia en la selección del paciente de alto riesgo.
Źródło :
Revista de neurologia [Rev Neurol] 2022 Dec 01; Vol. 75 (11), pp. 349-356.
Typ publikacji :
English Abstract; Journal Article; Review
MeSH Terms :
Early Detection of Cancer*
Epilepsy*/etiology
Humans ; Neoplasm Recurrence, Local ; Seizures ; Primary Prevention ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
Breast cancer screening rates of uninsured patients at South Main Clinic.
Autorzy :
Barber M; At the time this abstract was written, Melanie Barber, Meggan Chappell, Landon Henriksen, and Jenna Whippen were students in the PA program at the University of Utah in Salt Lake City. Leigh Elrod is a clinical assistant professor and Jennifer Coombs is a professor in the PA program at the University of Utah. The authors have disclosed no potential conflicts of interest, financial or otherwise.
Chappell M
Henriksen L
Whippen J
Elrod L
Coombs J
Pokaż więcej
Źródło :
JAAPA : official journal of the American Academy of Physician Assistants [JAAPA] 2022 Dec 01; Vol. 35 (12), pp. 1.
Typ publikacji :
Journal Article
MeSH Terms :
Early Detection of Cancer*
Breast Neoplasms*/diagnosis
Humans ; Female ; Medically Uninsured ; Ambulatory Care Facilities ; Mass Screening
Czasopismo naukowe
Tytuł :
USPSTF colorectal cancer screening update 2021: A review of evidence.
Autorzy :
Klimkiewicz P; Pawel Klimkiewicz is an FNP at the Internal Medicine Office of William Pelton, MD, in Plattsburgh, N.Y., and a DNP student at SUNY Brockport.
Pokaż więcej
Źródło :
The Nurse practitioner [Nurse Pract] 2022 Dec 01; Vol. 47 (12), pp. 37-42.
Typ publikacji :
Review; Journal Article
MeSH Terms :
Early Detection of Cancer*
Colorectal Neoplasms*/diagnosis
Colorectal Neoplasms*/prevention & control
Adult ; Humans ; Middle Aged ; Mass Screening ; Preventive Health Services ; Advisory Committees
Czasopismo naukowe
Tytuł :
Impact of Low-dose Chest CT Screening on the Association Between Rurality and Lung Cancer Outcomes.
Autorzy :
Hinojos M; University of Minnesota Medical School.
Li X; Department of Mathematics and Statistics, University of Minnesota Duluth.
Mikesell S; Divisions of Quality Management.
Studden S; Radiology.
Odean M; University of Minnesota Medical School.; Whiteside Institute for Clinical Research, Duluth MN.
Boylan MJ; Cardiothoracic Surgery.
Arvold DS; Internal Medicine.
Bachelder VD; Pulmonary Medicine.
Gowda N; Radiology.
Arvold ND; University of Minnesota Medical School.; Radiation Oncology, St. Luke's Hospital.; Whiteside Institute for Clinical Research, Duluth MN.
Pokaż więcej
Źródło :
American journal of clinical oncology [Am J Clin Oncol] 2022 Dec 01; Vol. 45 (12), pp. 519-525. Date of Electronic Publication: 2022 Nov 03.
Typ publikacji :
Journal Article
MeSH Terms :
Early Detection of Cancer*/methods
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/epidemiology
Humans ; Female ; United States/epidemiology ; Male ; Retrospective Studies ; Tomography, X-Ray Computed/methods ; Mass Screening
Czasopismo naukowe
Tytuł :
Controversy over colonoscopy for colorectal cancer screening.
Autorzy :
The Lancet Gastroenterology Hepatology
Pokaż więcej
Źródło :
The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2022 Dec; Vol. 7 (12), pp. 1061. Date of Electronic Publication: 2022 Oct 26.
Typ publikacji :
Editorial
MeSH Terms :
Early Detection of Cancer*
Colorectal Neoplasms*/diagnosis
Colorectal Neoplasms*/prevention & control
Humans ; Colonoscopy
Opinia redakcyjna
Tytuł :
Optimizing the implementation of lung cancer screening in Scotland: Focus group participant perspectives in the LUNGSCOT study.
Autorzy :
Cavers D; Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, Edinburgh, UK.
Nelson M; Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, Edinburgh, UK.
Rostron J; Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, Edinburgh, UK.
Robb KA; School of Health and Wellbeing, University of Glasgow, Glasgow, UK.
Brown LR; School of Medicine, University of St Andrews, St Andrews, UK.
Campbell C; Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, Edinburgh, UK.
Akram AR; Centre for Inflammation Research and Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK.
Dickie G; Care of the Usher Institute, University of Edinburgh, Edinburgh, Edinburgh, UK.
Mackean M; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK.
van Beek EJR; Edinburgh Imaging, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
Sullivan F; School of Medicine, University of St Andrews, St Andrews, UK.
Steele RJ; School of Medicine, Ninewells Hospital, University of Dundee, Dundee, UK.
Neilson AR; Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, Edinburgh, UK.
Weller D; Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, Edinburgh, UK.
Pokaż więcej
Źródło :
Health expectations : an international journal of public participation in health care and health policy [Health Expect] 2022 Dec; Vol. 25 (6), pp. 3246-3258. Date of Electronic Publication: 2022 Oct 20.
Typ publikacji :
Journal Article
MeSH Terms :
Early Detection of Cancer*/psychology
Lung Neoplasms*/diagnosis
Lung Neoplasms*/prevention & control
Male ; Humans ; Female ; Focus Groups ; Mass Screening/psychology ; Scotland ; Qualitative Research
Czasopismo naukowe
Tytuł :
Healthcare provider cultural competency and receptivity to colorectal cancer screening among African Americans.
Autorzy :
Dawadi A; Division of Public Health, College of Human Medicine, Michigan State University, Flint, USA.
Lucas T; Division of Public Health, College of Human Medicine, Michigan State University, Flint, USA.; Department of Epidemiology and Biostatistics, College of Human Medicine, Michigan State University, East Lansing, USA.
Drolet CE; Division of Public Health, College of Human Medicine, Michigan State University, Flint, USA.
Thompson HS; Department of Community Outreach and Engagement, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA.
Key K; Division of Public Health, College of Human Medicine, Michigan State University, Flint, USA.
Dailey R; Department of Family Medicine and Public Health Sciences, Wayne State University School of Medicine, Detroit, USA.
Blessman J; Department of Family Medicine and Public Health Sciences, Wayne State University School of Medicine, Detroit, USA.
Pokaż więcej
Źródło :
Psychology, health & medicine [Psychol Health Med] 2022 Dec; Vol. 27 (10), pp. 2073-2084. Date of Electronic Publication: 2021 Jun 22.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Early Detection of Cancer*/psychology
Colorectal Neoplasms*/diagnosis
Colorectal Neoplasms*/prevention & control
Colorectal Neoplasms*/psychology
Humans ; African Americans/psychology ; Cultural Competency ; Health Personnel
Czasopismo naukowe
Tytuł :
Comparing Latino Community Members' and Clinical Staff's Perspectives on Barriers and Facilitators to Colorectal Cancer Screening.
Autorzy :
Alpert EN; San Diego State University, 6363 Alvarado Court, Suite 103, San Diego, CA, 92120-4913, USA.; UC San Diego Moores Cancer Center, San Diego, CA, USA.
Clark T; San Diego State University, 6363 Alvarado Court, Suite 103, San Diego, CA, 92120-4913, USA.
Garcia-Alcaraz C; San Diego State University, 6363 Alvarado Court, Suite 103, San Diego, CA, 92120-4913, USA.
Eddington SN; Stanford University, Stanford, CA, USA.
Carrizosa C; San Diego State University Research Foundation, San Diego, CA, USA.
Haughton J; San Diego State University Research Foundation, San Diego, CA, USA.
de la Torre CL; San Diego State University Research Foundation, San Diego, CA, USA.
Garcia-Bigley F; Family Health Centers of San Diego, San Diego, CA, USA.
Arredondo EM; San Diego State University, 6363 Alvarado Court, Suite 103, San Diego, CA, 92120-4913, USA.
Ramers C; Family Health Centers of San Diego, San Diego, CA, USA.
Nodora J; UC San Diego, San Diego, CA, USA.
Wells KJ; San Diego State University, 6363 Alvarado Court, Suite 103, San Diego, CA, 92120-4913, USA. .; San Diego State University/UC San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, USA. .
Pokaż więcej
Źródło :
Journal of cancer education : the official journal of the American Association for Cancer Education [J Cancer Educ] 2022 Dec; Vol. 37 (6), pp. 1645-1653. Date of Electronic Publication: 2021 Apr 23.
Typ publikacji :
Journal Article
MeSH Terms :
Early Detection of Cancer*
Colorectal Neoplasms*/diagnosis
Colorectal Neoplasms*/prevention & control
Female ; Humans ; United States ; Middle Aged ; Adult ; Male ; Patient Acceptance of Health Care ; Health Knowledge, Attitudes, Practice ; Hispanic or Latino ; Mass Screening
Czasopismo naukowe
Tytuł :
Uptake of Colorectal Cancer Screening in 45 to 49 Year Olds: An Early-Inning View from the Endoscopy Suite.
Autorzy :
Imperiale TF; Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana; Center for Health Information and Communication, Health Services Research and Development, Richard L. Roudebush VA Medical Center, Indianapolis, Indiana; The Regenstrief Institute, Inc, Indianapolis, Indiana. Electronic address: .
Pokaż więcej
Źródło :
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2022 Dec; Vol. 20 (12), pp. 2722-2724. Date of Electronic Publication: 2022 Jul 20.
Typ publikacji :
Editorial
MeSH Terms :
Early Detection of Cancer*
Colorectal Neoplasms*/diagnosis
Colorectal Neoplasms*/prevention & control
Humans ; Mass Screening ; Endoscopy ; Colonoscopy
Opinia redakcyjna
Tytuł :
Assessment of Lung Cancer Screening Eligibility on NCI-Designated Cancer Center Websites.
Autorzy :
Paige SR; College of Journalism and Communications, University of Florida, Gainesville, FL, 32610, USA. .
Salloum RG; Department of Health Outcomes and Biomedical Informatics, University of Florida, Gainesville, FL, 32610, USA.; UF Health Cancer Center, University of Florida, Gainesville, FL, 32610, USA.
Carter-Harris L; Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Pokaż więcej
Źródło :
Journal of cancer education : the official journal of the American Association for Cancer Education [J Cancer Educ] 2022 Dec; Vol. 37 (6), pp. 1849-1854. Date of Electronic Publication: 2021 Sep 03.
Typ publikacji :
Review; Journal Article
MeSH Terms :
Early Detection of Cancer*/methods
Lung Neoplasms*/diagnosis
Lung Neoplasms*/prevention & control
Adult ; Humans ; Decision Making ; Mass Screening ; Health Personnel
Czasopismo naukowe
Tytuł :
One or two faecal immunochemical tests in an organised population-based colorectal cancer screening programme in Murcia (Spain).
Autorzy :
Tourne-Garcia C; Servicio de Promoción y Educación para la Salud, Dirección General de Salud Pública, Murcia, Spain.
Perez-Riquelme F; Servicio de Promoción y Educación para la Salud, Dirección General de Salud Pública, Murcia, Spain.
Monteagudo-Piqueras O; Servicio de Promoción y Educación para la Salud, Dirección General de Salud Pública, Murcia, Spain.
Fraser CG; Centre for Research into Cancer Prevention and Screening, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.
Yepes-Garcia P; Preventive Medicine, 58355Hospital Rafael Méndez, Murcia, Spain.
Pokaż więcej
Źródło :
Journal of medical screening [J Med Screen] 2022 Dec; Vol. 29 (4), pp. 231-240. Date of Electronic Publication: 2022 May 16.
Typ publikacji :
Journal Article
MeSH Terms :
Colorectal Neoplasms*/diagnosis
Colorectal Neoplasms*/epidemiology
Colorectal Neoplasms*/pathology
Early Detection of Cancer*/methods
Colonoscopy/methods ; Feces/chemistry ; Hemoglobins/analysis ; Humans ; Mass Screening/methods ; Occult Blood ; Spain/epidemiology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies